| # | % | |||||
|---|---|---|---|---|---|---|
| 251 | REMARK MEDIA INC | 22,222 | 1,000 | 0.00% | ||
| 252 | ImmunoCellular Therapeutics Lt | 225,909 | 0 | 0.00% | ||
| 253 | CEL SCI CORP | 48,975 | 0 | 0.00% | ||
| 254 | PLURISTEM THERAPEUTICS INC | 180,000 | 0 | 0.00% | ||
| 255 | CYTRX CORP | 321,429 | 0 | 0.00% | ||
| 256 | XOMA CORP DEL | 113,636 | 0 | 0.00% | ||
| 257 | Apricus Biosciences, Inc. | 175,000 | 0 | 0.00% | ||
| 258 | Quantum Fuel Systems Tech Worl | 110,202 | 0 | 0.00% | ||
| 259 | CLEVELAND BIOLABS INC | 109,375 | 0 | 0.00% | ||
| 260 | Caladrius Biosciences Inc | 22,500 | 0 | 0.00% | ||
| 261 | CYCLACEL PHARMACEUTICALS INC | 52,521 | 0 | 0.00% |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0001085146-16-003809, filed 2016.05.16).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
